Effect of CPAP on Myocardial Dysfunction in Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Patients
Effect of Nasal CPAP on Myocardial Dysfunction and Glycemic Control in Patients With Type 2 Diabetes, Obstructive Sleep Apnea and Obesity
Sponsor: Fundación Clínica Médica Sur
This NA trial investigates Continuous Positive Airway Pressure and Diabetes Mellitus, Type 2 and is currently completed. Fundación Clínica Médica Sur leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
▶ Show 1 earlier version
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Clínica Médica Sur
- Instituto Nacional de Enfermedades Respiratorias
- National Council of Science and Technology, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .